4//SEC Filing
Scadden David 4
Accession 0001650664-25-000102
CIK 0001650664other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:19 PM ET
Size
14.0 KB
Accession
0001650664-25-000102
Insider Transaction Report
Form 4
Scadden David
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-06+37,500→ 37,500 totalExercise: $1.91Exp: 2035-06-05→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026.
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001707715
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:19 PM ET
- Size
- 14.0 KB